ORASURE TECHNOLOGIES INC
OSURNasdaq
$3.87
↓ -2.3%Jul 17 close · end-of-day
Price
1Y↑ +21.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$269.6M
Enterprise Value
$92.7M
P/E
—
P/S
2.4
P/B
0.9
EV/EBITDA
—
PEG
—
FCF Yield
-17.8%
Dividend Yield
—
Revenue (TTM)
$113.0M
Net Income (TTM)
-$75.1M
Free Cash Flow (TTM)
-$47.9M
Gross Margin
42.2%
Operating Margin
-68.6%
Net Margin
-66.4%
ROE
-24.0%
ROIC
-44.9%
Debt / Equity
—
Net Cash
$177.0M
Return 1Y
+18.0%
Company profile
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. It operates in two segments, Diagnostics and Molecular Solutions. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.
- CEO
- Carrie E. Manner
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 840
- Headquarters
- Pennsylvania
- Website
- orasure.com
Management & directors
- Eglinton Manner CarriePresident & CEO
- Mcgrath Kenneth JChief Financial Officer
- Miller Michele MarieSVP Finance & CAO
Roles derived from SEC Form 4 filings.
Earnings
OSUR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$27.9M↓ -6.7%
Diluted EPS-$0.32↑ +52.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $171.7M | $233.7M | $387.5M | $405.5M | $185.8M | $115.0M |
| Gross profit | $101.9M | $117.6M | $148.4M | $171.7M | $79.4M | $48.2M |
| Operating income | -$5.2M | -$10.2M | -$22.2M | $32.7M | -$28.3M | -$72.0M |
| Net income | -$14.9M | -$23.0M | -$17.1M | $53.7M | -$19.5M | -$68.7M |
| Diluted EPS | $0.22 | -$0.32 | -$0.24 | $0.72 | -$0.26 | -$0.94 |
| Operating cash flow | $5.8M | -$35.4M | -$47.2M | $141.6M | $27.4M | -$49.0M |
| Free cash flow | -$20.9M | -$57.3M | -$54.0M | $135.8M | $23.6M | -$53.2M |
| Gross margin | 59.3% | 50.3% | 38.3% | 42.3% | 42.7% | 41.9% |
| Operating margin | -3.0% | -4.3% | -5.7% | 8.1% | -15.2% | -62.6% |
| Net margin | -8.7% | -9.8% | -4.4% | 13.2% | -10.5% | -59.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.3M | $39.9M | $37.4M | $29.9M | $31.2M | $27.1M | $26.8M | $27.9M |
| Gross profit | $24.7M | $17.1M | $13.6M | $12.3M | $13.2M | $11.8M | $11.0M | $11.8M |
| Operating income | -$2.7M | -$6.0M | -$12.4M | -$17.8M | -$18.0M | -$16.1M | -$20.1M | -$23.3M |
| Net income | -$615,000.00 | -$4.5M | -$10.8M | -$16.0M | -$19.7M | -$13.7M | -$19.3M | -$22.4M |
| Diluted EPS | -$0.01 | -$0.06 | -$0.14 | -$0.21 | -$0.26 | -$0.19 | -$0.28 | -$0.32 |
| Operating cash flow | $7.8M | $12.7M | $109,000.00 | -$19.7M | -$10.2M | -$10.1M | -$9.0M | -$13.9M |
| Free cash flow | $6.2M | $12.5M | -$347,000.00 | -$20.2M | -$12.2M | -$11.0M | -$9.9M | -$14.8M |
| Gross margin | 45.4% | 42.8% | 36.2% | 41.1% | 42.1% | 43.5% | 41.0% | 42.3% |
| Operating margin | -5.0% | -15.0% | -33.2% | -59.3% | -57.7% | -59.4% | -75.1% | -83.3% |
| Net margin | -1.1% | -11.3% | -28.8% | -53.6% | -63.0% | -50.6% | -72.1% | -80.1% |
Company news
May 20, 2026
May 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-26 | Boyd Steven Kyle | Award | 3,666 | $4.43 | $16,249.55 | filing |
| 2026-06-03 | McMahon Robert W. | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-06-03 | Gagliano Nancy J | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-06-03 | Marmora Lelio | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-06-03 | Bertrand John D. | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-06-03 | Boyd Steven Kyle | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-06-03 | Kenny John P. | Award | 46,106 | $0.00 | $0.00 | filing |
| 2026-05-14 | Boyd Steven Kyle | Buy | 25,000 | $2.99 | $74,750.00 | filing |
| 2026-05-13 | Marmora Lelio | Tax withholding | 28,406 | $3.02 | $85,786.12 | filing |
| 2026-05-13 | Boyd Steven Kyle | Buy | 25,000 | $3.02 | $75,500.00 | filing |
| 2026-05-13 | McMahon Robert W. | Tax withholding | 22,888 | $3.02 | $69,121.76 | filing |
| 2026-05-13 | Gagliano Nancy J | Tax withholding | 21,305 | $3.02 | $64,341.10 | filing |
| 2026-05-12 | Boyd Steven Kyle | Buy | 25,000 | $2.98 | $74,500.00 | filing |
| 2026-05-12 | Bertrand John D. | Award | 33,661 | $0.00 | $0.00 | filing |
| 2026-03-26 | Boyd Steven Kyle | Award | 5,246 | $3.10 | $16,249.49 | filing |
| 2026-03-26 | Boyd Steven Kyle | Tax withholding | 1,416 | $3.10 | $4,386.06 | filing |
| 2026-03-20 | McGrath Kenneth J· Chief Financial Officer | Buy | 32,300 | $2.93 | $94,600.24 | filing |
| 2026-03-20 | EGLINTON MANNER CARRIE· President & CEO | Buy | 32,300 | $2.93 | $94,597.01 | filing |
| 2026-03-13 | EGLINTON MANNER CARRIE· President & CEO | Buy | 22,022 | $3.00 | $66,032.97 | filing |
| 2026-03-13 | McGrath Kenneth J· Chief Financial Officer | Buy | 22,021 | $3.00 | $66,029.97 | filing |
| 2026-03-02 | Miller Michele Marie· SVP Finance & CAO | Award | 42,982 | $0.00 | $0.00 | filing |
| 2026-03-02 | McGrath Kenneth J· Chief Financial Officer | Award | 88,348 | $0.00 | $0.00 | filing |
| 2026-03-02 | EGLINTON MANNER CARRIE· President & CEO | Award | 355,464 | $0.00 | $0.00 | filing |
| 2026-03-01 | EGLINTON MANNER CARRIE· President & CEO | Tax withholding | 122,655 | $3.04 | $373,177.84 | filing |
| 2026-03-01 | EGLINTON MANNER CARRIE· President & CEO | Tax withholding | 56,116 | $3.04 | $170,732.93 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.